Prognostic potential of plasma Interleukin-6 levels as biomarker for long-term cognitive performance

被引：0
|
作者：
Coll-Martinez, Claudia [1 ,2 ,3 ,4 ]
Huertas Pons, Joana Maria [1 ,4 ]
Miguela Benavides, Albert [1 ]
Alvarez Bravo, Gary Ciceron [1 ,2 ,3 ,5 ]
Gifreu, Ariadna [1 ,2 ,3 ]
Salavedra Pont, Judit [1 ,2 ,3 ]
Gich Fulla, Jordi [1 ,2 ,3 ,5 ]
Ramio i Torrenta, Lluis [1 ,4 ,5 ,6 ]
Quiroga-Varela, Ana [1 ,4 ]
机构：
[1] Girona Biomed Res Inst IDIBGI, Neurodegenerat & Neuroinflammat Res Grp, Salt, Spain
[2] Dr Josep Trueta Univ Hosp, Salt, Spain
[3] Santa Caterina Hosp, Dept Neurol, Girona Neuroimmunol & Multiple Sclerosis Unit, Salt, Spain
[4] Carlos III Hlth Inst, RICORS, Red Enfermedades Inflamatorias RD21 0002 0063, Salt, Spain
[5] Univ Girona, Dept Med Sci, Girona, Spain
[6] Fundacio Hosp Olot & Comarcal Garrotxa, Girona, Spain
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1547/2088
引用
收藏
页码：981 / 981
页数：1
相关论文
共 50 条
  • [1] Prognostic value of serum interleukin-6 (IL-6) levels in long term care
    Maurel, Stephane
    Hamon, Brigitte
    Taillandier, Jean
    Rudant, Eric
    Bonhomme-Faivre, Laurence
    Trivalle, Christophe
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2007, 45 (01) : 65 - 71
  • [2] Interleukin-6 as Potential Prognostic Biomarker in Relapsing MOG Antibody Disease
    McDonald, J.
    Sattarnezhad, N.
    Tomczak, A.
    Sumera, J.
    Lock, C.
    Han, M. H.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 35 - 36
  • [3] Interleukin-6 as A Prognostic Biomarker in Perinatal Asphyxia
    Boskabadi, Hassan
    Maamouri, Gholamali
    Zakerihamidi, Maryam
    Bagheri, Fatemeh
    Mashkani, Baratili
    Mafinejad, Shahin
    Faramarzi, Rahelah
    Boskabadi, Abbas
    Khodashenas, Ezzat
    Heidari, Elaheh
    Rakhshanizadeh, Forough
    IRANIAN JOURNAL OF CHILD NEUROLOGY, 2021, 15 (03) : 119 - 130
  • [4] SERUM INTERLEUKIN-6 IN LONG-TERM HEMODIALYZED PATIENTS
    CAVAILLON, JM
    POIGNET, JL
    FITTING, C
    DELONS, S
    NEPHRON, 1992, 60 (03): : 307 - 313
  • [5] Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19
    Kappelmann, Nils
    Dantzer, Robert
    Khandaker, Golam M.
    PSYCHONEUROENDOCRINOLOGY, 2021, 131
  • [6] Interleukin-8 plasma levels as a potential biomarker for predicting middle-term cognitive outcomes
    Huertas Pons, Joana Maria
    Coll-Martinez, Claudia
    Miguela Benavides, Albert
    Gifreu, Ariadna
    Salavedra Pont, Judit
    Alvarez Bravo, Gary Ciceron
    Gich Fulla, Jordi
    Ramio i Torrenta, Lluis
    Quiroga-Varela, Ana
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 976 - 977
  • [7] Interleukin-6 as a Prognostic Biomarker in Ruptured Intracranial Aneurysms
    Kao, Hung-Wen
    Lee, Kwo-Whei
    Kuo, Chen-Ling
    Huang, Ching-Shan
    Tseng, Wan-Min
    Liu, Chin-San
    Lin, Ching-Po
    PLOS ONE, 2015, 10 (07):
  • [8] THROMBOPOIETIC EFFECTS OF INTERLEUKIN-6 IN LONG-TERM ADMINISTRATION IN MICE
    ISHIBASHI, T
    SHIKAMA, Y
    KIMURA, H
    KAWAGUCHI, M
    UCHIDA, T
    YAMAMOTO, T
    OKANO, A
    AKIYAMA, Y
    HIRANO, T
    KISHIMOTO, T
    MARUYAMA, Y
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (05) : 640 - 646
  • [9] LONG-TERM CONSEQUENCES OF INTERLEUKIN-6 OVEREXPRESSION IN TRANSGENIC MICE
    WOODROOFE, C
    MULLER, W
    RUTHER, U
    DNA AND CELL BIOLOGY, 1992, 11 (08) : 587 - 592
  • [10] Prognostic value of plasma interleukin-6 levels in chronic lymphocytic leukemias.
    Lai, R
    O'Brien, S
    Manshouri, T
    Rogers, A
    Kantarjian, H
    Keating, M
    Albitar, M
    BLOOD, 2000, 96 (11) : 716A - 716A
12345